Brain Diseases: Clinical Trials

3,144 trials for Brain Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1870 completed, 299 recruiting, 292 terminated, 259 unknown. 3144 Phase 1, 899 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13144Completed 1870, Recruiting 299, Terminated 292, Unknown 259, Active not recruiting 141, Withdrawn 136, Not yet recruiting 114, Suspended 20, Enrolling by invitation 13
Phase 2899Completed 428, Recruiting 116, Unknown 100, Terminated 88, Active not recruiting 63, Withdrawn 47, Not yet recruiting 40, Suspended 11, Enrolling by invitation 6

Follow Brain Diseases: new trials by email Literature Review of Brain Diseases trials Research Report on Brain Diseases

Trials (filtered) newest first · largest first

All 3,144 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma
JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease
Phase 1 / Phase 2Not yet recruitingJubilant Therapeutics Inc.1132028-04-012026-08-07
Terazosin for Dementia With Lewy Bodies
Terazosin Hydrochloride, Placebo - Dementia With Lewy Bodies
Phase 1 / Phase 2Not yet recruitingQiang Zhang402027-10-012026-03-12
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Fecal Microbiota Transplant - Parkinson Disease
Phase 1Not yet recruitingProgenaBiome102027-07-012026-10-09
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
H3K27M-EIEs - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-10-30
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
Formulation A, Formulation B, Formulation C - Healthy Volunteers
Phase 1 / Phase 2Not yet recruitingUniversity of Minnesota322027-04-012026-10-01
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Clinical Trial
Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase - GM1 Gangliosidoses, GM1 Gangliosidosis, Type I
Phase 1Not yet recruitingTippi Mackenzie52027-01-012026-08-31
Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage
Sirolimus (Rapamune®) - Post-hemorrhagic Hydrocephalus (PHH)
Phase 1 / Phase 2Not yet recruitingMassachusetts General Hospital152027-01-012026-06-25
Outside the Cage (OTC) Robotic Esophagectomy
OTC MIE Esophagectomy - Esophageal Cancer
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)312027-01-012026-03-18
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Trastuzumab Deruxtecan, Stereotactic Radiosurgery - Breast Cancer, HER2-positive Breast Cancer
Phase 1Not yet recruitingBaptist Health South Florida202027-01-012026-10-01
Relaxin Therapy for Atrial Fibrillation
Relaxin, Placebo - Atrial Fibrillation (AF), Arrhythmia
Phase 1 / Phase 2Not yet recruitingDeeptankar DeMazumder2082027-01-012026-01-22
Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Bevacizumab (intra-arterial) - Chronic Subdural Hematoma
Phase 1Not yet recruitingDheeraj Gandhi182027-01-012026-07-27
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)
Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells - High-grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 1Not yet recruitingUniversity of Florida242027-01-012026-10-30
The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction
Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), Aspirin Tablet - Cerebral Infarction
Phase 1SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction
Phase 1 / Phase 2SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
GD2, PSMA and CD276 CAR-T cells - Neuroblastoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute1002026-12-312026-10-30
Immune Modulatory DC Vaccine Against Brain Tumor
Immunomodulatory DC vaccine to target DIPG and GBM - Diffuse Intrinsic Pontine Glioma or Glioblastoma
Phase 1Not yet recruitingShenzhen Geno-Immune Medical Institute102026-12-312026-10-30
Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)
Tirofiban, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 1 / Phase 2Not yet recruitingDr David Hasan, M.D.822026-12-052026-11-04
Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease
Emtricitabine and tenofovir disoproxil fumarate combination, Placebo - Alzheimer's Disease
Phase 1Not yet recruitingBrigham and Women's Hospital202026-12-012026-08-31

Showing 20 of 3144. Sign in to see all of them.

Narrower conditions

Brain Neoplasms (589)  ·  Alzheimer Disease (558)  ·  Parkinson Disease (435)  ·  Glioblastoma (291)  ·  Stroke (282)  ·  Glioma (235)  ·  Astrocytoma (205)  ·  Central Nervous System Neoplasms (170)  ·  Gliosarcoma (156)  ·  Oligodendroglioma (149)  ·  Epilepsy (144)  ·  Ischemic Stroke (133)  ·  Dementia (102)  ·  Migraine Disorders (100)  ·  Medulloblastoma (94)

Broader conditions

Nervous System Diseases (3114)  ·  Central Nervous System Diseases (3098)  ·  Neurodegenerative Diseases (1120)  ·  Mental Disorders (738)  ·  Neoplasms by Site (698)  ·  Neurocognitive Disorders (695)  ·  Nervous System Neoplasms (685)  ·  Neoplasms (657)  ·  Dementia (588)  ·  Cardiovascular Diseases (573)  ·  Pathological Conditions, Signs and Symptoms (570)  ·  Vascular Diseases (570)  ·  Tauopathies (564)  ·  Basal Ganglia Diseases (554)

Interventions

Temozolomide (79)  ·  Radiotherapy (42)  ·  Radiosurgery (35)  ·  Donepezil (33)  ·  eslicarbazepine acetate (30)  ·  opicapone (30)  ·  Sodium Chloride (28)  ·  Bevacizumab (26)  ·  Saline Solution (23)  ·  Carboplatin (22)  ·  Transcranial Direct Current Stimulation (22)  ·  carbidopa, levodopa drug combination (22)  ·  Cyclophosphamide (21)  ·  Magnetic Resonance Spectroscopy (21)  ·  pembrolizumab (21)

Sponsors

National Cancer Institute (NCI) (85)  ·  Bial - Portela C S.A. (75)  ·  GlaxoSmithKline (41)  ·  Pfizer (41)  ·  Eli Lilly and Company (36)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (34)  ·  Merck Sharp & Dohme LLC (33)  ·  M.D. Anderson Cancer Center (29)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (29)  ·  Duke University (26)  ·  University of Florida (24)  ·  Mayo Clinic (22)  ·  AstraZeneca (21)  ·  H. Lundbeck A/S (21)  ·  University of California, San Francisco (20)

Countries

United States (1858)  ·  China (199)  ·  United Kingdom (187)  ·  Canada (153)  ·  Australia (130)  ·  France (123)  ·  Germany (112)  ·  Netherlands (81)  ·  Spain (76)  ·  South Korea (69)  ·  Japan (64)  ·  Sweden (52)  ·  Belgium (51)  ·  Israel (42)  ·  Italy (42)

Top investigators

Danna Jennings, MD (12)

Results publications

PMID 37624739, PMID 33175411, PMID 40680102, PMID 24524452, PMID 29480210, PMID 30741694, PMID 31127735, PMID 32250312, PMID 36463457, PMID 36602886, PMID 37996817, PMID 38489195, PMID 38588457, PMID 40739200, PMID 10816186, PMID 17562928, PMID 19717023, PMID 20734360, PMID 22163120, PMID 23377664, PMID 23545055, PMID 23860343, PMID 24412048, PMID 25789616, PMID 26925577, PMID 27955995, PMID 28403842, PMID 29063518, PMID 29063814, PMID 29671202, PMID 29749279, PMID 29862060, PMID 30052328, PMID 30134967, PMID 30355322, PMID 30361858, PMID 30739747, PMID 31048098, PMID 31710340, PMID 33236783, PMID 33332761, PMID 33754315, PMID 34174279, PMID 34389161, PMID 34521461, PMID 35949912, PMID 36196048, PMID 36279795, PMID 37171121, PMID 38072889

NIH funding

2014 (17), 2023 (17), 2019 (15), 2018 (14), 2015 (13), 2016 (11), 2025 (11), U01CA081457 (10), 2017 (8), P30CA033572 (8), U01CA137443 (7), 2009 (6), U01CA097452 (5), UM1CA081457 (5), UM1CA097452 (5)